ALSO NOTED: FDA blesses St. Jude heart valve; China Aoxing to sell narcotic for cancer pain;

> St. Jude Medical got the FDA's OK for a heart valve implant designed to protect against calcification. Report

> China Aoxing Pharmaceutical got its government's go-ahead to make and market Tilidine, a narcotic, to alleviate a shortage of meds for cancer pain. Report

> Beijing Med-Pharm has inked a deal to market and distribute Enablex, a Novartis drug for overactive bladder, in China. Report

> The leukemia drug dexamethasone causes extreme fatigue and sleeplessness in some children, according to a new study published in the online journal Cancer. Report

And Finally... Here's how to better predict liver toxicity: Use a teeny-tiny colony of living cells. Report

Suggested Articles

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.